期刊文献+

泛素蛋白酶体抑制剂MG-132对胃癌细胞增殖和凋亡的影响 被引量:4

Effects of ubiquitin-proteasome inhibitor MG-132 on proliferation and apoptosis of gastric carcinoma cells
下载PDF
导出
摘要 目的:研究泛素蛋白酶体抑制剂对胃癌细胞增殖和凋亡的影响。方法:将泛素蛋白酶体抑制剂MG-132加入胃癌细胞SGC7901,用四氮唑蓝(MTT)法测定细胞生长抑制效应,流式细胞仪检测细胞凋亡,免疫细胞化学检测生存素的表达。结果:MG-132对胃癌细胞有显著的抑制作用,24,48h的IC50分别为80.9,9.1μmol·L-1;MG1325.0μmol·L-1作用胃癌细胞24,48,72,96h后,细胞凋亡率分别为(4.2±s0.6)%,(30±4)%,(47±6)%,(53±6)%,生存素在胃癌细胞中呈高表达,经MG132作用后,表达明显降低。结论:MG132能显著抑制胃癌细胞的增殖、诱导其凋亡,并下调生存素的表达。 AIM: To investigate effects of ubiquitin-proteasome inhibitor on proliferation and apoptosis of gastric carcinoma cells. METHODS: The gastric carcinoma cells SGC-7901 were treated with MG-132. The effects of growth suppression on cells were evaluated with MTT assay. Apoptosis was measured by flow cytometry. Expression of survivin was detected by immunocytochemical technique. RESULTS: MG-132 showed obvious inhibitory effect on the growth of gastric carcinoma cells, IC_(50) of 24 and 48 h were 80.9 and (9.1) μmol·L^(-1) respectively. After treated with (5.0 μmol)·L^(-1) MG-132 for 24, 48, 72 and 96 h, the ratios of apoptotic cells were (4.2±0.6) %, (30±4) %, ((47±6) %) and (53±6) % respectively. Expression of survivin was high in gastric carcinoma cells and it was decreased in cells treated with MG-132. CONCLUSION: MG-132 can significantly inhibit the proliferation of gastric carcinoma cells and induce apoptosis with down ward regulation of survivin expression.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2005年第5期345-347,共3页 Chinese Journal of New Drugs and Clinical Remedies
关键词 泛素 蛋白酶抑制药 胃癌 细胞凋亡 MG-132 ubiquitin protease inhibitors stomach neoplasms apoptosis MG-132
  • 相关文献

参考文献5

  • 1LIM MS, ADAMSON A, LIN Z, et al. Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index[J]. Blood, 2002, 100(8):2950-2956.
  • 2LI M, CHEN D, SHILOH A, et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization [J]. Nature,2002, 416(6881) :648-653.
  • 3林法迎,侯健.蛋白酶体抑制药PS-341的研究进展[J].中国新药与临床杂志,2003,22(9):550-553. 被引量:2
  • 4HOCHWALD SN, LIND DS, MALATY J, et al. Antineoplastc therapyin colorectal cancer through proteasome inhibition [J]. Am Surg, 2003, 69(1) :15-23.
  • 5GUZMAN ML, NEERING SJ, UPCHURCH D, et al. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells [J]. Blood, 2001,98 (8) :2301-2307.

二级参考文献19

  • 1ELLIOTT PJ,ROSS JS. The proteasome: a new target for novel drug therapies[J]. Am J Clin Pathol, 2001,116(5) :637-646.
  • 2LIGHTCAP ES, McCORMACK TA, PIEN CS, et al. Proteasome inhibition measurements:clinical application[J]. Clin Chem, 2000,46(5) :673-683.
  • 3PAPANDREOU C,DALIANI D,MILLIKAN RE, et al. Phase I study of intravenous (I. V.) proteasome inhibitor PS-341 in patients(pts) with advanced malignancies[ J ]. Proc Am Soc Clin Oncol, 2001,20(11) :86.
  • 4HAMILTON AL,EDER J,PAVLICK AC, et al. PS-341 :phase I study of a novel proteasome inhibitor with pharmacodynamic endpoints[J]. Proc Am Soc Clin Oncol, 2001,20(11) :85.
  • 5STINCHOCOMBE TE,MITCHELL BS,DEPCIK-SMITH N, et al .PS-341 is active in multiple myeloma: preliminary report of a phase I trial of the proteasome inhibitor PS-341in patients with hematologic malignancies[ J ]. Blood, 2000,96 ( 11P1 ) : 516.
  • 6ADAMS J,PALOMBELLA VJ, SAUSVILLE EA, et al. Proteasome inhibitors:a novel class of potent and effective antitumor agents[J]. Cancer Res, 1999,59(11) :2615-2622.
  • 7CUSACK JC Jr, LIU R, HOUSTON M, et al. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341 : implications for systemic nuclear factor-κB inhibiton[J]. Cancer Res,2001,61(9):3535-3540.
  • 8HIDESHIMA T, RICHARDSON P, CHAUHAN D, et al. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis,and overcomes drug resistance in human multiple myeloma cells[J]. Cancer Res, 2001,61(7) :3071-3076.
  • 9SHAH SA, POTTER MW, McDADE TP, et al. 26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer[ J ]. J Cell Biochem, 2001,82( 1 ) : 110-112.
  • 10AN WG,HWANG SG,TREPEL JB, et al. Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent marks pf proteasome inhibition[ J ]. Leukemia 2000,14 (7) : 1276-1283.

共引文献1

同被引文献63

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部